We are live on ! Find out more
ACIU icon

AC Immune
ACIU

31 hedge funds and large institutions have $136M invested in AC Immune in 2016 Q3 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$55.4M
2
DFO
Duquesne Family Office
New York
+$25.9M
3
Temasek Holdings
Temasek Holdings
Singapore
+$23.1M
4
HIM
Hillhouse Investment Management
Cayman Islands
+$9.5M
5
PC
PointState Capital
New York
+$7.34M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
26
Virtu KCG Holdings
New York
$180K +$189K +10,915 New
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$165K +$173K +10,000 New
PHK
28
Point72 Hong Kong
Hong Kong
$66K +$69.1K +4,000 New
CLOS
29
Compagnie Lombard Odier SCmA
Switzerland
$33K +$34.6K +2,000 New
UBS Group
30
UBS Group
Switzerland
$25K +$26.6K +1,537 New
Credit Agricole
31
Credit Agricole
France
$16K +$17.3K +1,000 New
CCA
32
Catalyst Capital Advisors
New York
$5K +$4.89K +283 New
1
2

ACIU Hedge Fund Activity: Q3 2016 in Review

31 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2016, worth a combined $136M.

Buyers outnumbered sellers: 31 funds opened new ACIU positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $55.4M.

  • 31 institutional investors held AC Immune (ACIU) as of Q3 2016, up from 0 in Q2 2016.
  • Funds reported $136M of AC Immune stock for Q3 2016.
  • 31 funds opened new AC Immune positions in Q3 2016 and 0 closed out, a net change of +31 holders.
  • The largest AC Immune buyer in Q3 2016 was Fidelity Investments, an estimated $55.4M added.

Based on aggregated 13F filings for Q3 2016.